The invention provides novel hydantoin derivatives; processes for their preparation; pharmaceutical compositions containing them; a process for preparing the pharmaceutical compositions; and their use as MMP12 inhibitors.
[EN] HYDANTOIN DERIVATIVES USED AS MMP12 INHIBITORS<br/>[FR] NOUVEAUX COMPOSÉS